Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphomas

Cancer Discovery

Volumn 4, Issue 1, 2014, Pages 110-129

  Sangaletti, Sabina ^a   Tripodo, Claudio ^c   Vitali, Caterina ^a   Portararo, Paola ^a   Guarnotta, Carla ^c   Casalini, Patrizia ^b   Cappetti, Barbara ^a   Miotti, Silvia ^a   Pinciroli, Patrizia ^b   Fuligni, Fabio ^d   Fais, Franco ^e   Piccaluga, Pier Paolo ^d   Colombo, Mario P ^a  

^a Molecular Immunology Unit   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; OSTEONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL COMPARTMENTALIZATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD5; ANTIGENS, CD95; AUTOIMMUNITY; B-LYMPHOCYTES; CELLS, CULTURED; EXTRACELLULAR MATRIX; HUMANS; LYMPHOID TISSUE; LYMPHOMA; MICE; MICE, MUTANT STRAINS; NEUTROPHILS; NF-KAPPA B; OSTEONECTIN;

EID: 84891891729     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-13-0276     Document Type: Article

References (60)

1. Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, et al. Autoimmune and chronic infl ammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006;98:51-60.
2. Smedby KE, Askling J, Mariette X, Baecklund E. Autoimmune and infl ammatory disorders and risk of malignant lymphomas-an update. J Intern Med 2008;264:514-527.
3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classifi cation of tumours of haematopoietic and lymphoid tissues, fourth edition. WHO Press; 2008.
4. Dagklis A, Ponzoni M, Govi S, Cangi MG, Pasini E, Charlotte F, et al. Immunoglobulin gene repertoire in ocular adnexal lympho-mas: hints on the nature of the antigenic stimulation. Leukemia 2012; 26: 814-821.
5. Sakuma H, Nakamura T, Uemura N, Chiba T, Sugiyama T, Asaka M, et al. Immunoglobulin VH gene analysis in gastric MALT lympho-mas. Mod Pathology 2007;20:460-466.
6. Mannami T, Yoshino T, Oshima K, Takase S, Kondo E, Ohara N, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001;14: 641-649.
7. Zwick C, Fadle N, Regitz E, Kemele M, Stilgenbauer S, Buhler A, et al. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells. Blood 2013;121:4708-4717.
8. Garcia-Munoz R, Panizo C, Bendandi M, Llorente L. Autoimmunity and lymphoma: is mantle cell lymphoma a mistake of the receptor editing mechanism? Leuk Res 2009;33:1437-1439.
9. Cha SC, Qin H, Kannan S, Rawal S, Watkins LS, Baio FE, et al. Nons-tereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J Immunol 2013;190:4887-4898.
10. Dias C, Martins J, Dias G, Faria T, Brazao LR. B-cell lymphomagen-esis in autoimmune diseases: the missing links. Discov Med 2012;13: 417-424.
11. Mackay IR, Rose NR. Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol 2001;2:793-795.
12. Warsame AA, Aasheim HC, Nustad K, Troen G, Tierens A, Wang V, et al. Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity. Blood 2011;118:3331-3339.
13. Roozendaal R, Mebius RE. Stromal cell-immune cell interactions. Annu Rev Immunol 2011;29:23-43.
14. Mueller SN, Germain RN. Stromal cell contributions to the home-ostasis and functionality of the immune system. Nat Rev 2009;9: 618-629.
15. Bradshaw AD, Sage EH. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 2001;107:1049-1054.
16. Sangaletti S, Tripodo C, Cappetti B, Casalini P, Chiodoni C, Piconese S, et al. SPARC oppositely regulates infl ammation and fi brosis in bleomycin-induced lung damage. Am J Pathol 2011;179:3000-3010.
17. Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med 2003;198:1475-1485.
18. Tripodo C, Sangaletti S, Guarnotta C, Piccaluga PP, Cacciatore M, Giuliano M, et al. Stromal SPARC contributes to the detrimental fi brotic changes associated with myeloproliferation whereas its defi -ciency favors myeloid cell expansion. Blood 2012;120:3541-3554.
19. Piconese S, Costanza M, Tripodo C, Sangaletti S, Musio S, Pittoni P, et al. The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses. J Autoimmun 2011; 37: 300-310.
20. Malhotra D, Fletcher AL, Astarita J, Lukacs-Kornek V, Tayalia P, Gonzalez SF, et al. Transcriptional profi ling of stroma from infl amed and resting lymph nodes defi nes immunological hallmarks. Nat Immunol 2012;13:499-510.
21. Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity 2009;30:180-192.
22. Morse HC, Davidson WF, Yetter RA, Murphy ED, Roths JB, Coff-man RL. Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset. J Immunol 1982;129:2612-2615.
23. Fields ML, Sokol CL, Eaton-Bassiri A, Seo S, Madaio MP, Erik-son J. Fas/Fas ligand defi ciency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol 2001;167:2370-2378.
24. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001;19:595-621.
25. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
26. Boulianne B, Porfilio EA, Pikor N, Gommerman JL. Lymphotoxin-sensitive microenvironments in homeostasis and infl ammation. Front Immunol 2012;3:243.
27. Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, et al. B cell-helper neutrophils stimulate the diversifi cation and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012;13:170-180.
28. Oduro KA, Liu F, Tan Q, Kim CK, Lubman O, Fremont D, et al. Mye-loid skewing in murine autoimmune arthritis occurs in hematopoi-etic stem and primitive progenitor cells. Blood 2012;120:2203-2213.
29. Sangaletti S, Tripodo C, Chiodoni C, Guarnotta C, Cappetti B, Casa-lini P, et al. Neutrophil extracellular traps mediate transfer of cyto-plasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 2012;120:3007-3018.
30. Metzler KD, Fuchs TA, Nauseef WM, Reumaux D, Roesler J, Schulze I, et al. Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity. Blood 2011;117:953-959.
31. Pohl T, Gugasyan R, Grumont RJ, Strasser A, Metcalf D, Tarlinton D, et al. The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells. Proc Natl Acad Sci U S A 2002;99:4514-4519.
32. Herishanu Y, Perez-Galan P, Liu D, Biancotto A, Pittaluga S, Vire B, et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011;117:563-574.
33. Pillai S, Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev 2009;9:767-777.
34. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001;14:617-629.
35. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 2011;3:73ra20.
36. Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF, et al. Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 2004;279:44123-44132.
37. Martinek N, Shahab J, Saathoff M, Ringuette M. Haemocyte-derived SPARC is required for collagen-IV-dependent stability of basal laminae in Drosophila embryos. J Cell Sci 2008;121:1671-1680.
38. Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, Anderson JR, et al. Mice defi cient for the secreted glycoprotein SPARC/ osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 1998;17:1860-1870.
39. Lebbink RJ, de Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, Koch M, et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006;203:1419-1425.
40. Brondijk TH, De Ruiter T, Ballering J, Wienk H, Lebbink RJ, van Ingen H, et al. Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI. Blood 2010;115:1364-1373.
41. Zanesi N, Balatti V, Riordan J, Burch A, Rizzotto L, Palamarchuk A, et al. A sleeping beauty screen reveals NF-kB activation in CLL mouse model. Blood 2013;121:4355-4358.
42. Herreros B, Rodriguez-Pinilla SM, Pajares R, Martinez-Gonzalez MA, Ramos R, Munoz I, et al. Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place. Leukemia 2010;24:872-876.
43. Chen Z, Koralov SB, Kelsoe G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med 2000;192:1339-1352.
44. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929-939.
45. -/- mice. J Cell Biol 2004;167:1161-1170.
46. Carbone A, Santoro A. How I treat: diagnosing and managing "in situ" lymphoma. Blood 2011;117:3954-3960.
47. Onder L, Narang P, Scandella E, Chai Q, Iolyeva M, Hoorweg K, et al. IL-7-producing stromal cells are critical for lymph node remodeling. Blood 2012;120:4675-4683.
48. Meyaard L. The inhibitory collagen receptor LAIR-1 (CD305). J Leu-koc Biol 2008;83:799-803.
49. Omiya R, Tsushima F, Narazaki H, Sakoda Y, Kuramasu A, Kim Y, et al. Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivity. Immunology 2009;128:543-555.
50. Sangaletti S, Gioiosa L, Guiducci C, Rotta G, Rescigno M, Stoppac-Ciaro A, et al. Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J Cell Sci 2005;118:3685-3694.
51. Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al. Netting neutrophils induce endothelial damage, infi ltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011;187:538-552.
52. Knight JS, Kaplan MJ. Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Curr Opin Rheumatol 2012;24:441-450.
53. Jansen CA, Cruijsen CW, de Ruiter T, Nanlohy N, Willems N, Jans-sens-Korpela PL, et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 2007;37:914-924.
54. Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, Zoc-chi MR. Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. Leukemia 2008;22:980-988.
55. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, et al. Stro-mal gene signatures in large-B-cell lymphomas. N Engl J Med 2008;359:2313-2323.
56. Morse HC III, Anver MR, Fredrickson TN, Haines DC, Harris AW, Harris NL, et al. Bethesda proposals for classifi cation of lymphoid neoplasms in mice. Blood 2002;100:246-258.
57. Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo S, et al. Gene expression analysis of peripheral T cell lymphoma, unspecifi ed, reveals distinct profi les and new potential therapeutic targets. J Clin Invest 2007;117:823-834.
58. Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C, Tripodo C, et al. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes. Blood 2011; 117: 3596-3608.
59. Jenssen TK, Laegreid A, Komorowski J, Hovig E. A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001;28:21-28.
60. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.